Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Baxter International Inc (NYSE:BAX)

60.98
Delayed Data
As of Jun 26
 -0.40 / -0.65%
Today’s Change
42.22
Today|||52-Week Range
61.52
+37.53%
Year-to-Date
Activist fund aims to spur 'staid' Nestl into action
Jun 26 / FT.com - Paid Partner Content
2 Solid Medical Device Stocks to Scoop Up Right Away
Jun 16 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: American Woodmark, Lantheus Holdings, Baxter Internati...
Jun 22 / Zacks.com - Paid Partner Content
Baxter-Dorizoe Ink Deal to Expand Generic Injectables Line
Jun 15 / Zacks.com - Paid Partner Content
Baxter (BAX) Scales 52-Week High: What's Behind the Rally
Jun 22 / Zacks.com - Paid Partner Content
Weakness Seen in Enzymotec (ENZY) Estimates: Should You Stay Away?
Jun 13 / Zacks.com - Paid Partner Content
Buy These 5 Efficient Stocks Right Away
Jun 21 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close61.38
Today’s open61.38
Day’s range60.96 - 61.52
Volume1,911,293
Average volume (3 months)3,091,396
Market cap$33.4B
Dividend yield1.05%
Data as of 4:00pm ET, 06/26/2017

Growth & Valuation

Earnings growth (last year)+410.02%
Earnings growth (this year)+15.68%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)+1.96%
P/E ratio18.0
Price/Sales2.40
Price/Book4.00

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...-0.09-0.07%
ZTSZoetis Inc-0.06-0.10%
ALXNAlexion Pharmaceutic...-0.98-0.78%
INCYIncyte Corp-1.61-1.18%
Data as of 4:14pm ET, 06/26/2017

Financials

Next reporting dateJuly 20, 2017
EPS forecast (this quarter)$0.57
Annual revenue (last year)$10.2B
Annual profit (last year)$4.9B
Net profit margin48.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Joe Almeida
Vice President-
Operations
Scott Pleau
Corporate headquarters
Deerfield, Illinois

Forecasts